Alnylam Pharmaceuticals (ALNY.MX) Q1 2024 Earnings

Feb 15Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-38.28
-15.35
7.59
30.52

Details

Expected EPS
-21.455910000000003
Actual EPS
-13.111945
Surprise EPS
8.34
Surprise Percent
+38.89%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY.MX⁩) has reported earnings of ⁦-13.111945⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts